Fulgent Genetics, Inc. is a prominent player in the Healthcare sector, specifically operating within the Diagnostics & Research industry. Currently commanding a market capitalization of $520.61 Million, the stock has recently exhibited notable short-term volatility. Trading at $16.67, the asset has experienced a 2.02% gain over the last 24 hours and an impressive 11.51% surge over the past seven days. Despite this recent upward momentum, the broader technical and fundamental picture demands a careful, nuanced analysis.
Based on our proprietary technical scoring system, Fulgent Genetics earns a Total Score of -1, which translates to a Hold rating. The long-term trend remains firmly bearish, penalizing the stock with a -2 score, as the current price ($16.67) trades significantly below its 200-day Simple Moving Average of $22.72. This downward pressure is structurally confirmed by our trend strength indicator (-1 score): an elevated ADX of 36.73 coupled with the DMI- (29.12) outpacing the DMI+ (22.75). The RSI currently sits in a neutral zone at 43.13. However, short-term momentum indicators offer a glimmer of hope. The MACD histogram has turned positive (+1 score), signaling a bullish crossover, while the On-Balance Volume (OBV) sits comfortably above its 5-day moving average (+1 score), suggesting recent accumulation by active buyers.
In conclusion, this mixed technical outlook closely aligns with a highly challenging fundamental and earnings context. The company currently lacks a calculable P/E ratio—reflecting underlying profitability struggles—and offers no dividend yield to cushion volatility. Its latest earnings report revealed an EPS of -$0.03, accompanied by a staggering negative surprise of -24286.0%. With the next quarterly update slated for 01/05/2026, investors face an extended horizon of uncertainty. While historical fundamentals and long-term technicals scream caution, the recent short-term uptick in buying volume and MACD momentum prevents a full bearish downgrade, solidifying our prudent Hold stance.